Managing the Risks of Medicines: An Examination of FDA’s Application of Criteria for Requiring a REMS
Crossref DOI link: https://doi.org/10.1177/2168479018791560
Published Online: 2019-12-23
Published Print: 2019-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Seligman, Paul J.
Anguiano, Rebekah H.
Felix, Thomas
Stabi, Katie
Text and Data Mining valid from 2019-07-01
Article History
Received: 2 May 2018
Accepted: 3 July 2018
First Online: 23 December 2019